Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Chris Lange | Oct 10, 2022 at 11:40 AM EDT

Great Employment Report, Bad Ramifications: Analysts Upgrade or Downgrade Ford, Kroger, Merck and More

Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck,…

Lee Jackson | Sep 27, 2022 at 8:50 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Costco, Exxon, FedEx, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags, Unity Software and More

Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels,…

More CPI Inflation More Problems: Analysts Upgrade or Downgrade Block, CSX, Merck and More

Chris Lange | Sep 14, 2022 at 11:30 AM EDT

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

The bear market rally that started in June is over and it is clearly a time to move to safer…

Lee Jackson | Jun 6, 2022 at 8:45 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Cheniere Energy, Chewy, Costco, CrowdStrike, Spotify and More

Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New…

Paul Ausick | Apr 27, 2022 at 12:03 PM EDT

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.

Chris Lange | Apr 6, 2022 at 3:25 PM EDT

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.

Lee Jackson | Mar 18, 2022 at 7:26 AM EDT

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

A recent survey of global fund managers found that many have turned to health care for some stability in these…

Lee Jackson | Dec 20, 2021 at 9:00 AM EST

Monday’s Top Analyst Upgrades and Downgrades: AT&T, Deere, Eli Lilly, 3M, Starbucks, Roblox, Tapestry, Tesla and More

Monday's top analyst upgrades and downgrades included Adobe, Arista Networks, AT&T, Bristol-Myers Squibb, Canopy Growth, Deere, Eli Lilly, Invesco, Medtronic,…

Lee Jackson | Dec 10, 2021 at 8:40 AM EST

Friday’s Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Cloudflare, Diageo, Eli Lilly, Rio Tinto, Southwest Airlines and More

Friday’s top analyst upgrades and downgrades included Altice USA, AppLovin, Biogen, Bristol-Myers Squibb, Broadcom, Ciena, Cloudflare, Denison Mines, Diageo, Eli…

Lee Jackson | Nov 24, 2021 at 7:25 AM EST

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

With the potential for far lower returns in the coming year, total return becomes a key ingredient for investment success.…

Lee Jackson | Nov 18, 2021 at 7:35 AM EST

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets,…

Chris Lange | Nov 1, 2021 at 11:45 AM EDT

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More

Monday afternoon's analyst upgrades and downgrades included Bristol-Myers Squibb, Intel, Merck, Newell Brands, Snap, Spotify Technology and Tilray.

Lee Jackson | Nov 1, 2021 at 7:35 AM EDT

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer…

Lee Jackson | Aug 4, 2021 at 7:35 AM EDT

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for…

1 … 6 7 8 9 10 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Great Employment Report, Bad Ramifications: Analysts Upgrade or Downgrade Ford, Kroger, Merck and More

Tuesday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Costco, Exxon, FedEx, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags, Unity Software and More

More CPI Inflation More Problems: Analysts Upgrade or Downgrade Block, CSX, Merck and More

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

Monday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Cheniere Energy, Chewy, Costco, CrowdStrike, Spotify and More

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

Monday’s Top Analyst Upgrades and Downgrades: AT&T, Deere, Eli Lilly, 3M, Starbucks, Roblox, Tapestry, Tesla and More

Friday’s Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Cloudflare, Diageo, Eli Lilly, Rio Tinto, Southwest Airlines and More

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Great Employment Report, Bad Ramifications: Analysts Upgrade or Downgrade Ford, Kroger, Merck and More

Tuesday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Costco, Exxon, FedEx, Lucid, Medtronic, Micron Technology, Salesforce, Six Flags, Unity Software and More

More CPI Inflation More Problems: Analysts Upgrade or Downgrade Block, CSX, Merck and More

8 Safe ‘Strong Buy’ Health Care Dividend Stocks to Buy as Summer Bear Market Rally Ends

Monday’s Top Analyst Upgrades and Downgrades: Bristol-Myers, Cheniere Energy, Chewy, Costco, CrowdStrike, Spotify and More

Earnings Previews: AbbVie, AstraZeneca, Bristol-Meyers Squibb

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More

Fund Managers Pile Into Big Dividend Health Care Stocks: 8 ‘Strong Buy’ Winners

Monday’s Top Analyst Upgrades and Downgrades: AT&T, Deere, Eli Lilly, 3M, Starbucks, Roblox, Tapestry, Tesla and More

Friday’s Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Cloudflare, Diageo, Eli Lilly, Rio Tinto, Southwest Airlines and More

Top Strategist Says Health Care Could Rule in 2022: 5 Dividend Winners

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Monday Afternoon Analyst Upgrades and Downgrades: Bristol-Myers, Intel, Merck, Newell, Snap and More

5 Big Dividend Biotech and Pharmaceutical Stocks Have Strong Upside Potential

4 Big Pharma Dividend Stocks to Buy as Yields Near 2021 Lows

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do